Brought to you by
ECR 2019 / C-3635
Imaging evaluation of lung lesions treated with stereotactic ablative radiotherapy
Congress: ECR 2019
Poster No.: C-3635
Type: Scientific Exhibit
Keywords: Lung, Thorax, Nuclear medicine, CT, Gamma knife, PET-CT, VMAT and Tomotherapy, Radiation therapy / Oncology, Education, Radiotherapy techniques, Image guided radiotherapy, Tissue characterisation
Authors: S. Mennella1, I. Pulzato1, G. Ficarra2, E. Barabino1, S. vagge2, G. Cittadini2; 1Genova/IT, 2Genoa/IT


  1. Potters L, Kavanagh B, Galvin JM, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2010;76(2):326–332.
  2. Kirkpatrick JP, Kelsey CR, Palta M, et al. Stereotactic body radiotherapy: a critical review for nonradiation oncologists. Cancer 2014;120(7):942–954.
  3. Loo BW Jr, Chang JY, Dawson LA, et al. Stereotactic ablative radiotherapy: what’s in a name? Pract Radiat Oncol 2011;1(1):38–39.
  4. Iyengar P, Westover K, Timmerman RD. Stereotactic ablative radiotherapy (SABR) for non–small cell lung cancer. Semin Respir Crit Care Med 2013;34(6):845–854.
  5. Nguyen TK, Senan S, Bradley JD, Franks K, Giuliani M, Guckenberger M, Landis M, Loo BW Jr, Louie AV, Onishi H, Schmidt H, Timmerman R, Videtic GMM, Palma DA. Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study Pract Radiat Oncol. 2018 Mar-Apr;8(2):e71-e78. 
  6. Dahele M, Palma D, Lagerwaard F, Slotman B, Senan S. Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol. 2011;6:1221–1228.
  7. Choi YW, Munden RF, Erasmus JJ, et al. Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radiographics. 2004;24:985–997.
  8. Trovo M, Linda A, El Naqa I, Javidan-Nejad C, Bradley J. Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 2010;69(1):77–85.
  9. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M and Fletcher J: Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24: 4833-4839, 2006.
  10. Marcenaro M, Vagge S, Belgioia L, Agnese D, Lamanna G, Mantero E, Gusinu M, Garelli S, Cavagnetto F, Agostinelli S, Corvò R. Ablative or palliative stereotactic body radiotherapy with helical tomotherapy for primary or metastatic lung tumor. Anticancer Res. 2013Feb;33(2):655-60.
  11. PeulenH, Mantel F, Guckenberger M, Belderbos J, Werner-Wasik M, Hope A, Giuliani M, Grills I, Sonke JJ. Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):134-41.
  12. Huang K, Senthi S, Palma DA, et al. High risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. Radiother Oncol. 2013;109:51–57.
  13. Halpenny D, Ridge C, Hayes S, et al. Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy. Clin Imaging. 2015;39:254–258.
  14. Huang K, Dahele M, Senan S, et al. Radiographic changes after lung stereotactic ablative radiotherapy (SABR) -can we distinguish recurrence from fibrosis? A systematic review of the literature. Radiother Oncol. 2012;102: 335–342.
  15. Villaruz LC, Socinski MA. The clinical viewpoint: Definitions, limitations of RECIST, practical considerations of measurement. Clin Cancer Res. 2013;19:2629-2636.
POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more